HOME >> MEDICINE >> NEWS
NIH halts use of COX-2 inhibitor in large cancer prevention trial

The National Institutes of Health (NIH) announced today that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI). The study, called the Adenoma Prevention with Celecoxib (APC) trial, was stopped because analysis by an independent Data Safety and Monitoring Board (DSMB) showed a 2.5-fold increased risk of major fatal and non-fatal cardiovascular events for participants taking the drug compared to those on a placebo.

Additional cardiovascular expertise was added to the safety monitoring committees at the request of the Steering Committees for this trial after a September 2004 report that the COX-2 inhibitor rofecoxib (Vioxx) caused a two-fold increased risk of cardiovascular toxicities in a trial to prevent adenomas. The APC is a study of more than 2,000 people who have had a precancerous growth (adenomatous polyp) removed. They were randomized to take either 200 mg of celecoxib twice a day, 400 mg of celecoxib twice a day, or a placebo for three years. The trial began in early 2000 and is scheduled to have been completed by Spring 2005.

Investigators at the 100 sites in the APC trial located primarily in the United States, with a few additional sites in the United Kingdom, Australia, and Canada, have been instructed to immediately suspend study drug use for all participants on the trial, although the participants will remain under observation for the planned remainder of the study.

"Data from the report on rofecoxib (Vioxx) informed us of the need to focus on specific cardiovascular issues, and our Institutes brought in the experts to do so, said Elias A. Zerhouni, M.D., NIH Director. "Our overwhelming commitment is to advance the health and to protect the safety of participants in clinical trials. We are examining the use of these agents in all NIH-sponsored clinical studies. In addition, we
'"/>

Contact: John Burklow / Don Ralbovsky
301-496-5787
NIH/Office of the Director
17-Dec-2004


Page: 1 2

Related medicine news :

1. Success of new treatment halts international blood pressure drug trial
2. Researchers identify brain protein that halts progression of Alzheimers
3. New oral medication halts blindness in AIDS patients
4. Enzyme halts muscle waste in mouse models of most-common childhood muscular dystrophy
5. COX-2 inhibitors associated with blood pressure elevation
6. COX-2 product offers good and bad news in test tube strokes
7. COX-2 inhibitor increases the risk of heart attack in elderly adults with no history of heart attack
8. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine
9. Special JAMA commentary on lessons learned from troubles with COX-2 inhibitors
10. Estrogen-associated COX-2 pathways explain protection from heart disease in female mice
11. COX-2 inhibitor could be safest anti-inflammatory drug for older people

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... The Colorado Rural Health Center (CRHC) is proud ... in our community during National Rural Health Day 2018. National Rural Health Day falls ... serving the health needs of over 60 million people across the nation. , ...
(Date:11/16/2018)... CRANFORD, N.J. (PRWEB) , ... November 16, 2018 , ... ... every year in the U.S. are Veterans. To help provide care and support that ... have become a national partner of We Honor Veterans, a pioneering campaign developed by ...
(Date:11/16/2018)... ... November 16, 2018 , ... CompareRemit, a leading online ... Canada to India. The marketplace currently offers money transfer channels from the United ... in 2016, an estimated $23.3 billion was sent from Canada to other countries ...
(Date:11/15/2018)... ... November 15, 2018 , ... November 13, 2018, Lone Tree, ... therapies to her leading selection of minimally-invasive aesthetic treatments. PRP is one of ... any area of the body. Atagi Plastic Surgery & Skin Aesthetics in Lone ...
(Date:11/15/2018)... ... 15, 2018 , ... Over the last decade, SABRE , the global ... for National Breast Cancer Foundation (NBCF) . A mission-driven organization and proud partner ... proceeds have helped launch the National Mammography Program which has provided almost ...
Breaking Medicine News(10 mins):
(Date:11/17/2018)... ... ... Getting ready for the holidays but dread blowing your diet? Whether you ... certainly can enjoy the bounty of the season in a healthy way. , ... how much," says Ronald Stern, M.D., author of Meals, Movement and Meditation : ...
(Date:11/17/2018)... ... ... Dr. Sundardas, and his new podcast Your Life by Design , ... and clarity about your life’s priorities, relationships, health, and career. He will assist you ... joy in your life. , For the last 30 years, Dr. Sundardas has ...
(Date:11/16/2018)... ... ... America’s families are buckling under the financial burden of caring for their children and ... Silver Tsunami desperately hoping it won’t hit home. Consider this. According to the US ... you know there are only about 1.4 million beds available in assisted living facilities ...
Breaking Medicine Technology:
Cached News: